Several prospective epidemiological studies over the past 20 years concluded that ingestion of certain food or dietary components improves serum lipid profile and are effective in management of hyperlipidemia. The objective of this paper is to identify and quantify selective lipid lowering dietary components. This review focuses on identifying, quantifying and understanding the possible mechanism of action of soy, flaxseeds, oats and psyllium in improving lipid profile and reducing atherosclerotic cardiovascular disease (ASCVD) risk factor. A systematic search of database was performed to retrieve studies of published human studies and trials from 1995-2012, concentrating on recent systematic reviews, meta-analysis and intervention trials done to further elucidate the role of selective food (soy, oats, flaxseeds and psyllium) and their bioactive components (soy protein, soy isoflavones, flaxseed lignan, flaxseed omega 3 fatty acid, b-glucan, insoluble fiber) involved in improving lipid profile and reducing the cardiovascular disease risks. The findings quantify the amounts showing beneficial effects on serum lipid profile. Overall, the review of these clinical evidences suggested that inclusion of these food items can moderately but significantly reduce the risk of dyslipidemia, when consumed regularly as a part of a healthy diet and thus may help reduce any untoward cardiovascular event
INTRODUCTION
Cardiovascular diseases (CVD) are the most prevalent cause of death and disability in both developed as well as developing countries. INDIA is one of the leading nations in ASCVD and is already a global capital of diabetes. In 2005, 29% of deaths in INDIA occurred alone due to CVD 1 . According to the recent estimates about 2.9 crores India's population is burdened with CVD and may increase to 6.4 crores, if no early intervention steps are taken. Dyslipidemia has been found to be one of the most important contributing factors 2 .
Dyslipidemia describes a number of abnormalities in lipoprotein homeostasis including hypercholesterolemia and hypertriglceridemia. Several co-morbid conditions like myocardial infarction, stroke, atherosclerosis, nephropathy, fatty liver cirrhosis and many others are associated with dyslipidemia. Therefore, reductions in dyslipidemic conditions and eventually CHD risk begin with the adoption of a healthy lifestyle. Thus, as a part of a comprehensive strategy to reduce complications of hypercholesterolemia, NCEP (National Cholesterol Education Programme) endorsed the use of several lipid lowering dietary agents 3 . This review emphasize on the quantity of soy, flaxseeds, oats and psyllium that have shown to improve the lipid profile, the mechanisms of each bioactive component responsible in reducing the risk of ASCVD and several human clinical trials data regarding their safety and efficacy.
Bioactive components
Dietary Fiber (DF) are the edible parts of plants or analogous carbohydrate that are resistant to digestion & absorption in the human intestine with complete or partial fermentation in the large intestine and which promote beneficial physiological effects including laxation and/or blood glucose attenuation and /or blood cholesterol attenuation.
Total dietary fiber (TDF) occurs in 2 major forms i.e. soluble dietary fiber (SDF) and insoluble dietary fiber (IDF). (4.) DF content of various foods are mentioned in Table1
Mechanism of Action
Soluble fiber lowers total and LDL-c cholesterol which can be attributed to enhanced gastric emptying, intestinal binding of bile acids thus reducing entero-hepatic bile recirculation, lowered dietary cholesterol absorption, affects VLDL composition which then contains more amount of phospholipids and less of cholesterol, also improves satiety. It also undergoes fermentation to short chain fatty acids (SCFA) in the colon thus reducing endogenous synthesis of cholesterol. It also decreases dietary glucose absorption thereby down regulating cholesterol synthesizing anabolic hormone insulin release [7] [8] [9] [10] [11] [12] [13] .
Omega-3 fatty acid from a plant source They are essential fatty acids for competitive synthesis of eicosonoids which are antiinflammatory, anti aggregatory and anti-thrombotic in action [14] [15] . Additional physiologic functions of omega 3 fatty acids which may prevent ASCVD include several mechanisms such as; maintain fluidity of the cell membrane thus facilitating removal of cholesterol, down regulating phosphotidic acid phosphatase (PAP) and diacylglycerol acyl tranferase (DGAT) thus reducing fatty acid synthesis, also activates PPAR involved in B-oxidation of fatty acids, upregualting lipoprotein lipase (LPL) activity thus increasing fats hydrolysis. N-3 fatty acids also modulate sterol regulating element binding protein (SREBP) and increases degradation of apoprotein B which eventually decreases LDL-c secretion and transport [16] [17] [18] . Table 2 illustrates nutrient composition of flaxseed
Phytoestrogens
Are a diverse group of naturally occurring non steroidal plant compounds that, because of their structural similarity with estradiol (17-β-estradiol), have the ability to cause estrogenic or/ and antiestrogenic effects 20 . Phytoestrogen content of selective foods are discussed in Table 3 . There are 2 major classes of phytoestrogens including: Isoflavones contains major bioactive components i.e. daidzein and genistein. They are primarily present in soy as much as 3 mg/g dry weight of soy. Lignans and their major bioactive components secoisolariciresinol and matairesinol are primarily found in flaxseeds 21 .
Mechanism of Action
Clinical evidence suggest that phytoestrogens is effective in lowering serum cholesterol via a series of mechanism which include; up regulation of LDL-c receptor activity thus increasing its clearance, it also depresses the activity of platelet activating factor receptor antagonists eventually reducing oxidation of the lipid , the primary step in process of hypercholesterolemic atherosclerosis. Phytoestrogens also enhances the activity of cholesterol-7 hydoxylase which in turn decreases endogenous cholesterol synthesis. There is also down regulation of the enzyme tyrosine kinase thus reducing thrombin production and ultimately myocardial infarction risk (MI) risk [22] [23] [24] [25] [26] [27] .
Soy protein
Recently soybeans are considered by many agencies as a source of a complete protein.
Hence variety of foods such as salad dressings, beverage powders, cheese, infant formulas and others contains soy proteins. The nutritional value of soy protein is equivalent to that of animal protein of high BV. For instance, isolated soy protein has a PDCAAS (Protein Digestibility Corrected Amino Acid Score) of 1.0, which is the same as that of casein and egg protein. 100g of Whole soybeans contains 43.2 g of protein [28] [29] [30] . Biological value of various soy products like whole soybean, soy milk, soy protein isolates are 96.0, 91.0, and 74.0 respectively 31 .
Mechanism of Action
Various studies have shown that soy proteins effectively lowers cholesterol through series of mechanisms such as; it binds bile acids thus reducing enterohepatic recirculation of bile, it also up regulates the apo B and apo E receptor activity thus reduces serum LDL-c levels. Soy proteins have also shown to reduce HMG-CoA [31] [32] [33] .
Human studies
To identify the majority of human studies on cardiovascular effects of these food items we performed a systematic search of the following databases: PubMed, Medscape, MDconsult etc from 1995-2009. We used the headings "soluble fiber, botanical n-3 fatty acids, Phytoestrogens and soy proteins." and searched the terms "soy, flaxseeds, oats and psyllium." using this strategy we identified 75 relevant articles and book chapters. The description below highlights the information on potential CV application of this food items.
Epidemiological data
Epidemiological data concerning intake of fiber, n-3fatty acids, phytoestrogens and soy proteins are studied as all the discussed food items are a good sources of this bioactive components. Epidemiological data on dietary fiber and risk of ASCVD are extensive and suggest in general an inverse correlation between them. Several observational trials have found positive correlation between soy proteins and n-3 fatty acids and secondary prevention of ASCVD. Also observational studies revealed that lignans may reduce ASCVD morbidity and mortality.
The following section describes data from human studies that addresses the Quantity and Effects of soy, flax, oats and psyllium and their bioactive components on CV risk factors dyslipidemia and others like inflammation, blood pressure and glycemic control.
Bioactive Components Enriched Food Items Soy
Soy (glycine max) is a species of legume native to East Asia. The beans contain significant amounts of proteins (38%), isoflavones, dietary fiber (25-30%) and phytic acid. The principle carbohydrates (30-32%) of mature soybeans are the disaccharide sucrose (2.5-8.2%), trisaccharde raffinose (0.1-1.0%) and the tetrasaccharide stachyose (1.4-4.1%). The majority of soybean carbohydrates can be classed as belonging to dietary fiber. The Food Drug and Administration (FDA) have approved soy as an official cholesterollowering food, along with other heart and health benefits 35 .
The major bioactive components that are responsible for improving the lipid profile on soy interventions are dietary fiber, phytoestrogens and soy proteins and articles related to these are discussed in table 4.
To Summarize
The bulk of the evidence from five clinical trials [36] [37] [38] [39] [40] [41] . Suggest that soy proteins (20-40g/d) or soy isoflavones (30-150mg/d) can modestly but significantly (p=<0.05) reduce total and LDL cholesterol in both normal and hypercholesterolemic subjects, without a significant effects on HDL-c and TG's. Effects were more prominent in post menopausal women or in subjects with initial mild to moderate hypercholesterolemia. Desroches S., et al., concluded that soy was also effective in shifting LDL particle size to a less atherogenic pattern. Thus, replacing foods high in saturated fats, trans fats & cholesterol; by soy products containing 30-150 mg/d of isoflavones or 20-40g/d of soy protein have a positive effects against coronary risk factors and related co morbidities e.g.: type2 DM ,hypertension and others.
Flaxseeds
Flaxseed (linseed) is a smooth, flat and reddish-brown in color is native to the region extending from the eastern Mediterranean to INDIA. Whole flaxseeds contain 28% dietary fiber (7-10% soluble fiber, 11-18% insoluble fiber); 40% fats (57% of omega 3 fatty acids) and 21% proteins. it is also the richest source of phtoestrogens-lignans 42 .
Consumption of flaxseeds have shown to reduce total and LDL cholesterol as well as platelet aggregation 43, 44 . The major bioactive components responsible for hypolipidemidic action of flaxseeds are dietary fiber, omega3 fatty acids and lignans and human trials related to these are discussed in detailed in table 5.
To Summarize
The results of the above discussed 5 clinical trials [43] [44] [45] [46] [47] [48] suggest that flaxseeds (20-50g/d whole or partially defatted respectively) are efficacious in improving the lipid profile in both normal and mild-moderate hypercholesterolemic subjects. This can be due to the bioactive components in flax like fiber, n-3 fatty acids and lignans which via several mechanisms as discussed earlier have shown to have a positive association with reductions in serum total and LDL cholesterol. The effects of flax seeds were more prominent in subjects with initial hypercholesterolemia like in postmenopausal women. They have also shown to have beneficial effects on other CVD risk factors like ratios of TC: HDL, LDL: HDL reductions in Apo B 100 and also Lp (A) a strong predictor of CVD. Thus daily incorporation of 20-50g of whole or partially defatted seeds respectively is effective in improving lipid profile.
Oats
Oats most commonly are available as 
To Summarize
The results from these studies [50] [51] [52] [53] [54] [55] [56] suggest that oats beta glucan is efficacious in significantly improving lipid profile as it was able to reduce TC and LDL-c in normal as well as hypercholesterolemic subjects significantly (p=< 0.05). Its intervention also significantly increased HDL levels (Villasmil R et al.) . It was also effective in decreasing LDL: HDL and TC: HDL ratios from the baseline significantly. Queenen et al., also found that oats beta glucan is a most fermentable fiber and produces the highest levels of SCFA butyrate compared to inulin and guar gum in vivo. Oat bran also proven to be beneficial in premenopausal women as it increased HDL-c levels and reduced LDL and TC levels Oats was also able to reduce classical CVD risk marker i.e. systolic blood pressure (SBP) significantly (p=0.026) in the trial conducted by Saltzman E et al. thus daily incorporation of 25-150g/d of oats or 2.5-6.0g of beta glucan is effective in the treatment of mildmoderate dyslipidemia.
Psyllium
Psyllium seed husk also known as isabgol are the seeds of plant Plantago otava. They are indigestible by the human intestine, thus helps in holding large amounts of water and making the stools bulky and soft for easy defecation; therefore they are used in the treatment of constipation, Irritable bowel syndrome, diarrhea etc. As early as in 1998, the FDA already have approved a healthy claim on daily incorporation of 3-12grams of psyllium along with a low fat diet may reduce risk of heart disease 57 . The hypolipidemic effects of psyllium mucilage have been discussed by various epidemiological studies in table 7.
To Summarize
Various human clinical trials on psyllium [58] [59] [60] [61] [62] suggest that this mucilage enriched food item is effective in lowering total cholesterol, LDL-c, triglycerides and improving the concentrations of good cholesterol HDL-c in the serum of normal and hypercholesterolemic subjects. Also the effects were more prominent in postmenopausal women as concluded by Ganji V et al. Psyllium was also effective in lowering Apo B100: ApoA1, TC: HDL. LDL: HDL and also increasing conc. of Apo A1; the apoprotein of HDL; thus reducing the primary and secondary ASCVD risk factors. Moreyra A, et al also concluded that 15g/d of psyllium intervention was as effective in lowering cholesterol as 20mg of simvastatin alone. Therefore, psyllium 5-15g/d is an effective adjunct therapy and may provide an alternative to drug therapy for mild-moderate hypercholesterolemic individuals.
CONCLUSION
Dyslipidemia and ASCVD morbidity is increasing at an alarming rate nationwide and thus it becomes essential to prevent or treat dyslipidemia to regress the associated metabolic derangements. Fortunately today we can combat this situation initially through diet and physical activity before switching on to cholesterol lowering drug therapy. Merely by including the discussed hypolipidemic dietary agents in the required dosage as inferred from researches and recommendations i.e. oats 45-150g/d or beta glucan 2.5-6g/g; 20-25g of soy protein or 30-150mg of isoflavones; flaxseeds 20-50g of whole or partially defatted respectively; psyllium 5-15g per day along with a low fat NCEP followed diet and recommended physical exercise are significantly effective in improving serum lipid profile. The discussed food items may be effective in preventing, reversing or managing most prevalent chronic conditions as mentioned earlier, and hence may be claimed as to be "first line therapy" in dyslipidemia management. They can simply be incorporated in ones daily diet as they are less expensive, readily available, relatively have no side effects, practical and effective in recommended low dosages. They are proven to be more effective in mild-moderate hyperlipidemics like postmenopausal women who are hesitant to follow a life-long drug therapy for improving their mildly deranged lipid profile. This review attempts to not only enlist the effects, possible mechanism and bioactive components of the food item but also to quantify the same to have a desired effect on individual lipid profile.
Limitations
While the majority of the published intervention studies suggest a lipid lowering effects of moderate doses of these food items administration, question remains about the
